Professor | Yijin Wang | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Yijin Wang
Contact Information	wangyj3@sustech.edu.cn
Language ability	English, Chinese
Province	Guangdong

Upload Avatar (500 x 500)

Name

Yijin Wang

Contact Information

wangyj3@sustech.edu.cn

Language ability

English, Chinese

Province

Guangdong

University/Lab Affiliation and Title	Southern University of Science and Technology
Faculty	Medical School
Academic Background & Achievements	2012/11–2016/09, Erasmus University Medical Center, Hepatology, PhD 2010/09–2012/08, Wageningen University & Research Center, Biotechnology Medicine, Master 2006/09–2010/07, Nanjing Medical University, Biotechnology, Bachelor
Work Experience	2020/11-Present, Southern University of Science and Technology, School of Medicine, Associate Professor 2016/09-2020/10, PLA General Hospital Fifth Medical Center, Pathology Diagnosis and Research Center, Associate Researcher
Awards	2021: Chinese Medical Science and Technology Award, Third Prize in Medical Science and Technology 2020: Travel Award by Asia-Pacific Hepatology Society (APASL) 2019: Beijing Science and Technology Rising Star by Beijing Municipal Science and Technology Commission 2019: Innovative Talent Construction Engineering Talent by PLA General Hospital 2019: Young Scholar Award by European Association for the Study of the Liver (EASL) 2019: Excellent Paper Award at Beijing Liver Disease Conference by Beijing Medical Association 2018: Young Scholar Award by European Association for the Study of the Liver (EASL) 2018: Young Scholar Award by Asia-Pacific Hepatology Society (APASL) 2018: Excellent Paper Award at Beijing Liver Disease Conference by Beijing Medical Association 2017: Veldhovenbeurs Award by Dutch Hepatology Society (NVGE) 2017: Excellent Paper at Joint Academic Conference on Fatty Liver Disease by Chinese Medical Association 2017: Excellent Paper at Beijing Liver Disease Academic Conference by Beijing Medical Association 2014: Young Scholar Award by European Association for the Study of the Liver (EASL)

University/Lab Affiliation and Title

Southern University of Science and Technology

Faculty

Medical School

Academic Background & Achievements

2012/11–2016/09, Erasmus University Medical Center, Hepatology, PhD
2010/09–2012/08, Wageningen University & Research Center, Biotechnology Medicine, Master
2006/09–2010/07, Nanjing Medical University, Biotechnology, Bachelor

Work Experience

2020/11-Present, Southern University of Science and Technology, School of Medicine, Associate Professor
2016/09-2020/10, PLA General Hospital Fifth Medical Center, Pathology Diagnosis and Research Center, Associate Researcher

Awards

2021: Chinese Medical Science and Technology Award, Third Prize in Medical Science and Technology
2020: Travel Award by Asia-Pacific Hepatology Society (APASL)
2019: Beijing Science and Technology Rising Star by Beijing Municipal Science and Technology Commission
2019: Innovative Talent Construction Engineering Talent by PLA General Hospital
2019: Young Scholar Award by European Association for the Study of the Liver (EASL)
2019: Excellent Paper Award at Beijing Liver Disease Conference by Beijing Medical Association
2018: Young Scholar Award by European Association for the Study of the Liver (EASL)
2018: Young Scholar Award by Asia-Pacific Hepatology Society (APASL)
2018: Excellent Paper Award at Beijing Liver Disease Conference by Beijing Medical Association
2017: Veldhovenbeurs Award by Dutch Hepatology Society (NVGE)
2017: Excellent Paper at Joint Academic Conference on Fatty Liver Disease by Chinese Medical Association
2017: Excellent Paper at Beijing Liver Disease Academic Conference by Beijing Medical Association
2014: Young Scholar Award by European Association for the Study of the Liver (EASL)

Areas of Focus	Viral hepatitis translational research Antiviral drug development Host-virus interactions Natural immune response mechanisms Clinical cohort studies on hepatitis E Mitochondrial dynamics in sepsis Non-infectious liver diseases Invasive diagnostic markers for liver diseases
Publications	TMBIM6 prevents VDAC1 multimerization and improves mitochondrial quality control to reduce sepsis-related myocardial injury, Zhou H, Dai Z, Li J, Wang J, Zhu H, Chang X, Wang Y, 2023 Serine/threonine kinase 3 promotes oxidative stress and mitochondrial damage in septic cardiomyopathy through inducing Kelch-like ECH-associated protein 1 phosphorylation and nuclear factor erythroid 2-related factor 2 degradation, Zhu H, Dai Z, Liu X, Zhou H, Wang Y, 2023 Interaction between dual specificity phosphatase-1 and cullin-1 attenuates alcohol-related liver disease by restoring p62-mediated mitophagy, Li R, Dai Z, Liu X, Wang C, Huang J, Xin T, Tong Y, Wang Y, 2023 The role and mechanism of action of mitophagy in various liver diseases, Wang C, Wang Y, 2022 Hepatitis E virus infection activates NLRP3 inflammasome antagonizing interferon response but therapeutically targetable, Li Y, Yu P, Kessler AL, Shu J, Liu X, Liang Z, Wang Y, Pan Q, 2022 Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, 2020 SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19, Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, 2020 Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus, Wang Y, Zhou X, Debing Y, Chen K, Van Der Laan LJ, Neyts J, 2014 Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient, Wang Y, Chen G, Pan Q, Zhao J, 2018 Recapitulating hepatitis E virus-host interactions and facilitating antiviral drug discovery in human liver-derived organoids, Li P, Li Y, Wang Y, Liu J, Lavrijsen M, Li Y, 2022 Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality, Wang Y, Rao H, Chi X, Li B, Liu H, Wu L, 2019 Hepatitis E virus infection in acute non-traumatic neuropathy: A large prospective case-control study in China, Wang Y, Wang S, Wu J, Jiang Y, Zhang H, Li S, 2018 Incidence, predictors and prognosis of genotype 4 hepatitis E related liver failure: A tertiary nested case-control study, Wang Y, Liu H, Liu S, Yang C, Jiang Y, Wang S, 2019 Nonalcoholic fatty liver disease is associated with lower hepatitis B viral load and antiviral response in pediatric population, Wang L, Wang Y, Liu S, Zhai X, Zhou G, Lu F, 2019 Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication, Wang Y, Wang W, Xu L, Zhou X, Shokrollahi E, Felczak K, 2016 Poor Outcomes of Acute Hepatitis E in Patients With Cirrhotic Liver Diseases Regardless of Etiology, Wang Y, Metselaar HJ, Peppelenbosch MP, Pan Q, 2020 Chronic hepatitis E in solid-organ transplantation: the key implications of immunosuppressants, Wang Y, Metselaar HJ, Peppelenbosch MP, Pan Q, 2014 RDW, NLR and RLR in predicting liver failure and prognosis in patients with hepatitis E virus infection, Wu J, Zhang X, Liu H, Guo N, Pan Q, Wang Y, 2019 Chronic hepatitis E in an immunocompetent patient, Wang Y, Liu S, Pan Q, Zhao J, 2019 Mitochondrial DNA from hepatocytes induces upregulation of interleukin-33 expression of macrophages in nonalcoholic steatohepatitis, Gao Y, Wang Y, Liu H, Liu Z, Zhao J, 2020 Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: A randomised open-label trial, Wang J, Huang A, Wang Y, Ji D, Liang Q, Zhao J, 2022 Clinical and pathological investigation of patients

Areas of Focus

Viral hepatitis translational research
Antiviral drug development
Host-virus interactions
Natural immune response mechanisms
Clinical cohort studies on hepatitis E
Mitochondrial dynamics in sepsis
Non-infectious liver diseases
Invasive diagnostic markers for liver diseases

Publications

TMBIM6 prevents VDAC1 multimerization and improves mitochondrial quality control to reduce sepsis-related myocardial injury, Zhou H, Dai Z, Li J, Wang J, Zhu H, Chang X, Wang Y*, 2023
Serine/threonine kinase 3 promotes oxidative stress and mitochondrial damage in septic cardiomyopathy through inducing Kelch-like ECH-associated protein 1 phosphorylation and nuclear factor erythroid 2-related factor 2 degradation, Zhu H, Dai Z, Liu X, Zhou H, Wang Y*, 2023
Interaction between dual specificity phosphatase-1 and cullin-1 attenuates alcohol-related liver disease by restoring p62-mediated mitophagy, Li R, Dai Z, Liu X, Wang C, Huang J, Xin T, Tong Y, Wang Y*, 2023
The role and mechanism of action of mitophagy in various liver diseases, Wang C, Wang Y*, 2022
Hepatitis E virus infection activates NLRP3 inflammasome antagonizing interferon response but therapeutically targetable, Li Y, Yu P, Kessler AL, Shu J, Liu X, Liang Z, Wang Y*, Pan Q*, 2022
Pathological findings of COVID-19 associated with acute respiratory distress syndrome, Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, 2020
SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19, Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, 2020
Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus, Wang Y, Zhou X, Debing Y, Chen K, Van Der Laan LJ, Neyts J, 2014
Chronic Hepatitis E in a Renal Transplant Recipient: The First Report of Genotype 4 Hepatitis E Virus Caused Chronic Infection in Organ Recipient, Wang Y, Chen G, Pan Q, Zhao J, 2018
Recapitulating hepatitis E virus-host interactions and facilitating antiviral drug discovery in human liver-derived organoids, Li P, Li Y, Wang Y, Liu J, Lavrijsen M, Li Y, 2022
Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality, Wang Y, Rao H, Chi X, Li B, Liu H, Wu L, 2019
Hepatitis E virus infection in acute non-traumatic neuropathy: A large prospective case-control study in China, Wang Y, Wang S, Wu J, Jiang Y, Zhang H, Li S, 2018
Incidence, predictors and prognosis of genotype 4 hepatitis E related liver failure: A tertiary nested case-control study, Wang Y, Liu H, Liu S, Yang C, Jiang Y, Wang S, 2019
Nonalcoholic fatty liver disease is associated with lower hepatitis B viral load and antiviral response in pediatric population, Wang L, Wang Y, Liu S, Zhai X, Zhou G, Lu F, 2019
Cross Talk between Nucleotide Synthesis Pathways with Cellular Immunity in Constraining Hepatitis E Virus Replication, Wang Y, Wang W, Xu L, Zhou X, Shokrollahi E, Felczak K, 2016
Poor Outcomes of Acute Hepatitis E in Patients With Cirrhotic Liver Diseases Regardless of Etiology, Wang Y, Metselaar HJ, Peppelenbosch MP, Pan Q, 2020
Chronic hepatitis E in solid-organ transplantation: the key implications of immunosuppressants, Wang Y, Metselaar HJ, Peppelenbosch MP, Pan Q, 2014
RDW, NLR and RLR in predicting liver failure and prognosis in patients with hepatitis E virus infection, Wu J, Zhang X, Liu H, Guo N, Pan Q, Wang Y, 2019
Chronic hepatitis E in an immunocompetent patient, Wang Y, Liu S, Pan Q, Zhao J, 2019
Mitochondrial DNA from hepatocytes induces upregulation of interleukin-33 expression of macrophages in nonalcoholic steatohepatitis, Gao Y, Wang Y, Liu H, Liu Z, Zhao J, 2020
Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: A randomised open-label trial, Wang J, Huang A, Wang Y, Ji D, Liang Q, Zhao J, 2022
Clinical and pathological investigation of patients

Viral Hepatitis Translational Research Antiviral Drugs Host-Virus Interaction Immune Response Clinical Studies Hepatitis E Mitochondrial Dynamics Non-Infectious Liver Disease Diagnostic Markers

Wei Hou - Wuhan University

Yan Liu - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us